# Rapamycin in Combination With Low-dose Aracytin in Elderly Acute Myeloid Leukemia Patients

> **NCT00235560** · PHASE2 · COMPLETED · sponsor: **University Hospital, Toulouse** · enrollment: 50 (actual)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** rapamycin

## Key facts

- **NCT ID:** NCT00235560
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2024-02-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00235560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00235560, "Rapamycin in Combination With Low-dose Aracytin in Elderly Acute Myeloid Leukemia Patients". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00235560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*